Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Fibrogen Inc CS (NQ: FGEN )

19.91 USD +0.61 (+3.16%)
Official Closing Price Updated: 7:56 PM EDT, Apr 16, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,887,200
Open 19.34
Bid (Size) 19.63 (5)
Ask (Size) 19.85 (10)
Prev. Close 19.30
Today's Range 18.91 - 20.00
52wk Range 18.12 - 57.21
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
FGEN EQUITY ALERT: Kessler Topaz Meltzer & Check, LLP Announces that a Securities Fraud Class Action Lawsuit was filed on Behalf of Investors of FibroGen, Inc.
From GlobeNewswire News Releases
BREAKING NEWS: ROSEN, A LEADING LAW FIRM, Encourages FibroGen, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline – FGEN
From GlobeNewswire News Releases

Performance

YTD
-47.02%
-47.02%
1 Month
-39.06%
-39.06%
3 Month
-54.77%
-54.77%
6 Month
-56.49%
-56.49%
1 Year
-49.84%
-49.84%

More News

Read More
FIBROGEN DEADLINE ALERT
From NewMediaWire
Portnoy Law: Lawsuit Filed On Behalf of FibroGen, Inc. Investors
From GlobeNewswire News Releases
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against FibroGen, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
From PR Newswire
FGEN CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against FibroGen Inc.
From Business Wire News Releases
FibroGen Receives Rare Pediatric Disease Designation from the U.S. FDA for Pamrevlumab for the Treatment of Duchenne Muscular Dystrophy
From GlobeNewswire News Releases
SHAREHOLDER ALERT: CLAIMSFILER REMINDS DOX, FGEN, GOEV, GOEVW INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Robbins LLP Announces That FibroGen, Inc. (FGEN) is Being Sued for Misleading Shareholders
From Business Wire News Releases
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ebang, 3D Systems, Amdocs, and FibroGen and Encourages Investors to Contact the Firm
From GlobeNewswire News Releases
Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline for Securities Fraud Class Action Lawsuit Filed Against FibroGen, Inc.
From Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.